Management of diastolic heart failure following cardiac surgery

European Journal of Cardio-thoracic Surgery

Volumn 35, Issue 2, 2009, Pages 241-249

  Alsaddique, Ahmed A ^a   Royse, Alistair G ^b,c   Royse, Colin F ^b,c   Fouda, Mohammed A ^d  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

^d KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Cardiac surgery; Diastolic; Heart failure; Postoperative

Indexed keywords

AMIODARONE; DIGOXIN; DIURETIC AGENT; ESMOLOL; LEVOSIMENDAN; NESIRITIDE; SOTALOL; VERAPAMIL;

ACUTE KIDNEY FAILURE; CARDIAC RESYNCHRONIZATION THERAPY; DIABETES MELLITUS; DIASTOLIC HEART FAILURE; HEART EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART SURGERY; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; HYPERTENSION; PATHOPHYSIOLOGY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; VALVULAR HEART DISEASE;

CARDIAC SURGICAL PROCEDURES; CARDIOVASCULAR AGENTS; HEART FAILURE, DIASTOLIC; HUMANS; PERIOPERATIVE CARE; TERMINOLOGY AS TOPIC;

EID: 58549095421     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2008.10.038     Document Type: Review

References (80)

1. Vasan R.S., and Levy D. Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation 101 (2000) 2118-2121
2. Gaasch W.H., and Zile M.R. Left ventricular diastolic dysfunction and diastolic heart failure. Annu Rev Med 55 (2004) 373-394
3. Kitzman D.W., Little W.C., Brubaker P.H., Anderson R.T., Hundley W.G., Marburger C.T., Brosnihan B., Morgan T.M., and Stewart K.P. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 288 (2002) 2144-2150
4. Brederlau J., Kredel M., Wurmb T., Dirks J., Schwemmer U., Broscheit J., Roewer N., and Greim C.A. Transesophageal echocardiography for non-cardiac surgery patients: superfluous luxury or essential diagnostic tool?. Anesthetist 55 (2006) 937-940 933-942
5. Poelaert J.I., Trouerbach J., De Buyzere M., Everaert J., and Colardyn F.A. Evaluation of transesophageal echocardiography as a diagnostic and therapeutic aid in a critical care setting. Chest 107 (1995) 774-779
6. Wake P.J., Ali M., Carroll J., Siu S.C., and Cheng D.C. Clinical and echocardiographic diagnoses disagree in patients with unexplained hemodynamic instability after cardiac surgery. Can J Anaesth 48 (2001) 778-783
7. Alsaddique A.A. Recognition of diastolic heart failure in the postoperative heart. Eur J Cardiothorac Surg 34 6 (2008) 1141-1148
8. Zile M.R., and Brutsaert D.L. New concepts in diastolic dysfunction and diastolic heart failure: part I: diagnosis, prognosis, and measurements of diastolic function. Circulation 105 (2002) 1387-1393
9. Vasan R.S., Benjamin E.J., and Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol 26 (1995) 1565-1574
10. Paulus W.J., Tschope C., Sanderson J.E., Rusconi C., Flachskampf F.A., Rademakers F.E., Marino P., Smiseth O.A., De Keulenaer G., Leite-Moreira A.F., Borbely A., Edes I., Handoko M.L., Heymans S., Pezzali N., Pieske B., Dickstein K., Fraser A.G., and Brutsaert D.L. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 28 (2007) 2539-2550
11. Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, Redfield MM, Tajik AJ. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation 2000;10,102(15):1788-94.
12. Mansencal N., Bouvier E., Joseph T., Farcot J.C., Pillière R., Redheuil A., Lacombe P., Jondeau G., and Dubourg O. Value of tissue Doppler imaging to predict left ventricular filling pressure in patients with coronary artery disease. Echocardiography 21 2 (2004) 133-138
13. Kirkpatrick JN, Vannan MA, Narula J, Lang RM. Echocardiography in heart failure: applications, utility, and new horizons. J Am Coll Cardiol 2007; 31,50(5):381-96.
14. Sharma R., Pellerin D., Gaze D.C., Mehta R.L., Gregson H., Streather C.P., Collinson P.O., and Brecker S.J. Mitral peak Doppler E-wave to peak mitral annulus velocity ratio is an accurate estimate of left ventricular filling pressure and predicts mortality in end-stage renal disease. J Am Soc Echocardiogr 19 3 (2006) 266-273
15. Okura H., Takada Y., Kubo T., Iwata K., Mizoguchi S., Taguchi H., Toda I., Yoshikawa J., and Yoshida K. Tissue Doppler-derived index of left ventricular filling pressure, E/E′, predicts survival of patients with non-valvular atrial fibrillation. Heart 92 9 (2006) 1248-1252
16. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function. Circulation 2002;19,105(11):1387-93.
17. Deswal A. Diastolic dysfunction and diastolic heart failure: mechanisms and epidemiology. Curr Cardiol Rep 7 3 (2005) 178-183
18. Burkhoff D, Maurer MS, Packer M. Heart failure with a normal ejection fraction: is it really a disorder of diastolic function? Circulation 2003;11,107(5):656-8.
19. Groban L. Diastolic dysfunction in the older heart. J Cardiothorac Vasc Anesth 19 (2005) 228-236
20. Aurigemma G.P., and Gaasch W.H. Clinical practice. Diastolic heart failure. N Engl J Med 351 (2004) 1097-1105
21. Zile M.R., Baicu C.F., and Gaasch W.H. Diastolic heart failure - abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med 350 (2004) 1953-1959
22. Kass D.A., Bronzwaer J.G., and Paulus W.J. What mechanisms underlie diastolic dysfunction in heart failure?. Circ Res 94 (2004) 1533-1542
23. Kostis J.B., Davis B.R., Cutler J., Grimm Jr. R.H., Berge K.G., Cohen J.D., Lacy C.R., Perry Jr. H.M., Blaufox M.D., Wassertheil-Smoller S., Black H.R., Schron E., Berkson D.M., Curb J.D., Smith W.M., McDonald R., Applegate W.B., and SHEP Cooperative Research Group. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 278 (1997) 212-216
24. Mottram P.M., Haluska B.A., Leano R., Carlier S., Case C., and Marwick T.H. Relation of arterial stiffness to diastolic dysfunction in hypertensive heart disease. Heart 91 (2005) 1551-1556
25. Iribarren C., Karter A.J., Go A.S., Ferrara A., Liu J.Y., Sidney S., and Selby J.V. Glycemic control and heart failure among adult patients with diabetes. Circulation 103 (2001) 2668-2673
26. Liu J.E., Palmieri V., Roman M.J., Bella J.N., Fabsitz R., Howard B.V., Welty T.K., Lee E.T., and Devereux R.B. The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the Strong Heart Study. J Am Coll Cardiol 37 (2001) 1943-1949
27. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment. Circulation 2002;26,105(12):1503-8.
28. Klapholz M., Maurer M., Lowe A.M., Messineo F., Meisner J.S., Mitchell J., Kalman J., Phillips R.A., Steingart R., Brown Jr. E.J., Berkowitz R., Moskowitz R., Soni A., Mancini D., Bijou R., Sehhat K., Varshneya N., Kukin M., Katz S.D., Sleeper L.A., and Le Jemtel T.H. Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry. J Am Coll Cardiol 43 (2004) 1432-1438
29. Zile M.R., and Brutsaert D.L. New concepts in diastolic dysfunction and diastolic heart failure: part II: causal mechanisms and treatment. Circulation 105 (2002) 1503-1508
30. Owan T.E., Hodge D.O., Herges R.M., Jacobsen S.J., Roger V.L., and Redfield M.M. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355 3 (2006) 251-259
31. Royse C.F., Royse A.G., Soeding P.F., and Blake D.W. Shape and movement of the interatrial septum predicts change in pulmonary capillary wedge pressure. Ann Thorac Cardiovasc Surg 7 (2001) 79-83
32. Pinsky M.R. Cardiovascular issues in respiratory care. Chest. 128 5 Suppl. 2 (2005) 592S-597S
33. Pinsky M.R. Heart-lung interactions. Curr Opin Crit Care 13 5 (2007) 528-531
34. Bendjelid K., Schütz N., Suter P.M., Fournier G., Jacques D., Fareh S., and Romand J.A. Does continuous positive airway pressure by face mask improve patients with acute cardiogenic pulmonary edema due to left ventricular diastolic dysfunction?. Chest 127 3 (2005) 1053-1058
35. Moritz F., Benichou J., Vanheste M., Richard J.C., Line S., Hellot M.F., Bonmarchand G., and Muller J.M. Boussignac continuous positive airway pressure device in the emergency care of acute. Eur J Emerg Med 10 3 (2003) 204-208
36. Bersten A.D., Holt A.W., Vedig A.E., Skowronski G.A., and Baggoley C.J. Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure delivered by face mask. N Engl J Med 325 26 (1991 26) 1825-1830
37. Tsuyuki R.T., McKelvie R.S., Arnold J.M., Avezum Jr. A., Barretto A.C., Carvalho A.C., Isaac D.L., Kitching A.D., Piegas L.S., Teo K.K., and Yusuf S. Acute precipitants of congestive heart failure exacerbations. Arch Intern Med 161 (2001) 2337-2342
38. Pirracchio R., Cholley B., De Hert S., Solal A.C., and Mebazaa A. Diastolic heart failure in anaesthesia and critical care. Br J Anaesth 98 6 (2007) 707-721
39. Granton J., and Moric J. Pulmonary vasodilators-treating the right ventricle. Anesthesiol Clin 26 2 (2008) 337-353
40. Natori S, Hasebe N, Jin YT, Matsusaka T, Ido A, Matsuhashi H, Ihara T, Kikuchi K. Inhaled nitric oxide modifies left ventricular diastolic stress in the presence of vasoactive agents in heart failure. Am J Respir Crit Care Med 2003; 15,167(6):895-901.
41. Aurigemma G.P., and Gaasch W.H. Diastolic heart failure. N Engl J Med 351 (2004) 1097-1105
42. Bagshaw S.M., Galbraith P.D., Mitchell L.B., Sauve R., Exner D.V., and Ghali W.A. Prophylactic amiodarone for prevention of atrial fibrillation after cardiac surgery: a meta-analysis. Ann Thorac Surg 82 5 (2006) 1927-1937
43. Saltman A.E. Is it time to choose amiodarone for postoperative atrial fibrillation?. J Thorac Cardiovasc Surg 125 6 (2003) 1202-1203
44. Ahmed A., Rich M.W., Love T.E., Lloyd-Jones D.M., Aban I.B., Colucci W.S., Adams K.F., and Gheorghiade M. Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial. Eur Heart J 2 (2006) 178-186
45. Ahmed A., Rich M.W., Fleg J.L., Zile M.R., Young J.B., Kitzman D.W., Love T.E., Aronow W.S., Adams Jr. K.F., and Gheorghiade M. Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial. Circulation 114 5 (2006) 397-403
46. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B; American College of Cardiology; American Heart Association Task Force on Practice Guidelines; American College of Chest Physicians; International Society for Heart and Lung Transplantation; Heart Rhythm Society. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005;112(12):e154-e235.
47. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, Tavazzi L, Smiseth OA, Gavazzi A, Haverich A, Hoes A, Jaarsma T, Korewicki J, Lévy S, Linde C, Lopez-Sendon JL, Nieminen MS, Piérard L, Remme WJ; Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005;26(11):1115-40.
48. Little W.C., and Brucks S. Therapy for diastolic heart failure. Prog Cardiovasc Dis 47 6 (2005) 380-388
49. Wu E.B., and Yu C.M. Management of diastolic heart failure - a practical review of pathophysiology and treatment trial data. Int J Clin Pract 59 10 (2005) 1239-1246
50. Chatterjee K., and De Marco T. Role of nonglycosidic inotropic agents: indications, ethics, and limitations. Med Clin North Am 87 (2003) 391-418
51. Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC, Xavier D, Chrolavicius S, Greenspan L, Pogue J, Pais P, Liu L, Xu S, Málaga G, Avezum A, Chan M, Montori VM, Jacka M, Choi P, POISE Study Group. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomized controlled trial. Lancet 2008;31,371(9627):1839-47.
52. Andersen SS, Hansen ML, Gislason GH, Folke F, Schramm TK, Fosbøl E, Sørensen R, Rasmussen S, Abildstrøm SZ, Madsen M, Køber L, Torp-Pedersen C. Mortality and reinfarction among patients using different beta-blockers for secondary prevention after a myocardial infarction. Cardiology 2008; 9,112(2):144-50 [Epub ahead of print].
53. Everly M.J., Heaton P.C., and Cluxton Jr. R.J. Beta-blocker underuse in secondary prevention of myocardial infarction. Ann Pharmacother 38 2 (2004) 286-293
54. Sear J.W., Giles J.W., Howard-Alpe G., and Foëx P. Perioperative beta-blockade, 2008: what does POISE tell us, and was our earlier caution justified?. Br J Anaesth 101 2 (2008) 135-138
55. Mitchell R.G., Stoddard M.F., Ben-Yehuda O., Aggarwal K.B., Allenby K.S., Trillo R.A., Loyd R., Chang C.T., and Labovitz A.J. Esmolol in acute ischemic syndromes. Am Heart J 144 5 (2002) E9
56. Kirshenbaum J.M., Kloner R.A., Antman E.M., and Braunwald E. Use of an ultra short-acting beta-blocker in patients with acute myocardial ischemia. Circulation 72 4 (1985) 873-880
57. Yoshida Y., Terajima K., Sato C., Akada S., Miyagi Y., Hongo T., Takeda S., Tanaka K., and Sakamoto A. Clinical role and efficacy of landiolol in the intensive care unit. J Anesth 22 1 (2008) 64-69
58. Kobayashi M., Machida N., Mitsuishi M., and Yamane Y. Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure. Am J Hypertens 17 (2004) 1112-1119
59. Abernethy D.R., and Schwartz J.B. Calcium-antagonist drugs. N Engl J Med 341 19 (1999 4) 1447-1457
60. Setaro J.F., Zaret B.L., Schulman D.S., Black H.R., and Soufer R. Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance. Am J Cardiol 66 12 (1990) 981-986
61. Nishimura R.A., Schwartz R.S., Holmes Jr. D.R., and Tajik A.J. Failure of calcium channel blockers to improve ventricular relaxation in humans. J Am Coll Cardiol 21 1 (1993) 182-188
62. Yip G.W., Wang M., Wang T., Chan S., Fung J.W., Yeung L., Yip T., Lau S.T., Lau C.P., Tang M.O., Yu C.M., and Sanderson J.E. The Hong Kong diastolic heart failure study: a randomized controlled trial of diuretics, irbesartan and ramipril on quality of life, exercise capacity, left ventricular global and regional function in heart failure with a normal ejection fraction. Heart 94 (2008) 573-580
63. Yamamoto K., Mano T., Yoshida J., Sakata Y., Nishikawa N., Nishio M., Ohtani T., Hori M., Miwa T., and Masuyama T. ACE inhibitor and angiotensin II type 1 receptor blocker differently regulate ventricular fibrosis in hypertensive diastolic heart failure. J Hypertens 23 (2005) 393-400
64. Bergstrom A., Andersson B., Edner M., Nylander E., Persson H., and Dahlstrom U. Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC). Eur J Heart Fail 6 (2004) 453-461
65. Yoshida J., Yamamoto K., Mano T., Sakata Y., Nishikawa N., Nishio M., Ohtani T., Miwa T., Hori M., and Masuyama T. AT1 receptor blocker added to ACE inhibitor provides benefits at advanced stage of hypertensive diastolic heart failure. Hypertension 43 (2004) 686-691
66. Siirilä-Waris K., Suojaranta-Ylinen R., and Harjola V.P. Levosimendan in cardiac surgery. J Cardiothorac Vasc Anesth 19 3 (2005) 345-349
67. Follath F., Cleland J.G., Just H., Papp J.G., Scholz H., Peuhkurinen K., Harjola V.P., Mitrovic V., Abdalla M., Sandell E.P., and Lehtonen L. Steering Committee and Investigators of the Levosimendan Infusion versus Dobutamine (LIDO) Study Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomized double-blind trial. Lancet 360 9328 (2002) 196-202
68. Follath F. Can we believe in levosimendan?. Arq Bras Cardiol 90 3 (2008) 146-147
69. Toller W.G., and Stranz C. Levosimendan, a new inotropic and vasodilator agent. Anesthesiology 104 3 (2006) 556-569
70. Wylie J.V., and Tsao L. Nesiritide for the treatment of decompensated heart failure. Expert Rev Cardiovasc Ther 2 6 (2004) 803-813
71. Bobadilla R.V., Oppelt T.F., and Hirshy T.C. Nesiritide treatment of noncardiogenic pulmonary edema. Ann Pharmacother 37 4 (2003) 530-533
72. Topol E.J. Nesiritide - not verified. N Engl J Med 353 2 (2005) 113-116
73. Abraham W.T., Fisher W.G., Smith A.L., Delurgio D.B., Leon A.R., Loh E., Kocovic D.Z., Packer M., Clavell A.L., Hayes D.L., Ellestad M., Trupp R.J., Underwood J., Pickering F., Truex C., McAtee P., Messenger J., and MIRACLE Study Group. Multicenter in sync randomized clinical evaluation cardiac resynchronization in chronic heart failure. N Engl J Med 346 24 (2002) 1845-1853
74. Leclercq C., and Kass D.A. Retiming the failing heart: principles and current clinical status of cardiac resynchronization. J Am Coll Cardiol 39 (2002) 194-201
75. Beshai J.F., Grimm R.A., Nagueh S.F., Baker II J.H., Beau S.L., Greenberg S.M., Pires L.A., Tchou P.J., and RethinQ Study Investigators. Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. N Engl J Med 357 24 (2007) 2461-2471
76. Waggoner A.D., Faddis M.N., Gleva M.J., De Las Fuentes L., Osborn J., Heuerman S., and Davila-Roman V.G. Cardiac resynchronization therapy acutely improves diastolic function. J Am Soc Echocardiogr 18 3 (2005) 216-220
77. Waggoner A.D., Faddis M.N., Gleva M.J., de las Fuentes L., and Dávila-Román V.G. Improvements in left ventricular diastolic function after cardiac resynchronization therapy are coupled to response in systolic performance. J Am Coll Cardiol 46 12 (2005) 2244-2249
78. Bursi F., Weston S.A., Redfield M.M., Jacobsen S.J., Pakhomov S., Nkomo V.T., Meverden R.A., and Roger V.L. Systolic and diastolic heart failure in the community. JAMA 296 18 (2006) 2209-2216
79. Vasan R.S., and Benjamin E.J. Diastolic heart failure - no time to relax. N Engl J Med 344 1 (2001) 56-59
80. Groban L., and Dolinski S.Y. Transesophageal echocardiographic evaluation of diastolic function. Chest 128 5 (2005) 3652-3663